We are live on ! Find out more
AZN icon

AstraZeneca
AZN

449 hedge funds and large institutions have $10.8B invested in AstraZeneca in 2016 Q3 according to their latest regulatory filings, with 82 funds opening new positions, 154 increasing their positions, 120 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

308% more call options, than puts

Call options by funds: $138M | Put options by funds: $33.7M

228% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 25

75% more funds holding in top 10

Funds holding in top 10: 4 → 7 (+3)

28% more repeat investments, than reductions

Existing positions increased: 154 | Existing positions reduced: 120

24% more capital invested

Capital invested by funds: $8.72B → $10.8B (+$2.1B)

13% more funds holding

Funds holding: 397 → 449 (+52)

1.66% more ownership

Funds ownership: 11.43% → 13.09% (+1.7%)

Holders
449
Holders Change
+52
Holders Change %
+13.1%
% of All Funds
11.98%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.19%
New
82
Increased
154
Reduced
120
Closed
25
Calls
$138M
Puts
$33.7M
Net Calls
+$104M
Net Calls Change
+$35.1M

Top Buyers

1
Dodge & Cox
Dodge & Cox
California
+$316M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$180M
3
ClearBridge Investments
ClearBridge Investments
New York
+$171M
4
Bank of America
Bank of America
North Carolina
+$146M
5
Viking Global Investors
Viking Global Investors
Connecticut
+$136M

Top Sellers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$212M
2
CI
Cambiar Investors
Colorado
-$93.2M
3
JP Morgan Chase
JP Morgan Chase
New York
-$42.5M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$31.8M
5
HI
Honeywell International
North Carolina
-$25.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIBC Asset Management
151
CIBC Asset Management
Ontario, Canada
$1.99M +$1.98M +30,275 New
AG
152
Advisor Group
Arizona
$1.94M +$236K +3,607 +14%
EA
153
Emerald Acquisition
Washington
$1.93M -$848K -12,978 -31%
HCM
154
Howland Capital Management
Massachusetts
$1.9M -$174K -2,657 -8%
Geode Capital Management
155
Geode Capital Management
Massachusetts
$1.88M -$259K -3,960 -12%
BUB
156
BBVA USA Bancshares
Texas
$1.86M -$363K -5,549 -16%
TCM
157
Texan Capital Management
Texas
$1.84M – – –
CS
158
Credit Suisse
Switzerland
$1.83M +$47.7K +729 +3%
FBT
159
First Bankers Trust
Kentucky
$1.77M +$37.6K +575 +2%
Walleye Trading
160
Walleye Trading
New York
$1.74M +$1.73M +26,421 New
CFP
161
Cornerstone Financial Partners
North Carolina
$1.71M +$1.7M +26,062 New
NFA
162
Nationwide Fund Advisors
Ohio
$1.71M -$52.3K -800 -3%
Baird Financial Group
163
Baird Financial Group
Wisconsin
$1.7M -$30.9K -473 -2%
OLA
164
Oliver Luxxe Assets
New Jersey
$1.68M +$119K +1,824 +8%
CIBC World Market
165
CIBC World Market
Ontario, Canada
$1.64M +$476K +7,282 +41%
GWM
166
Geneos Wealth Management
Colorado
$1.63M +$1M +15,350 +165%
SLG
167
Stanley-Laman Group
Pennsylvania
$1.54M -$13.3K -203 -0.9%
Two Sigma Advisers
168
Two Sigma Advisers
New York
$1.54M -$1.26M -19,240 -45%
PP
169
Prospector Partners
Connecticut
$1.53M -$1.9M -29,100 -56%
IB
170
Intrust Bank
Kansas
$1.52M -$97.5K -1,492 -6%
PAM
171
Premier Asset Management
Illinois
$1.5M +$682K +10,437 +84%
GPCM
172
Granite Point Capital Management
Massachusetts
$1.48M +$1.47M +22,500 New
CIM
173
Calvert Investment Management
Maryland
$1.46M -$30K -459 -2%
CA
174
Commerzbank Aktiengesellschaft
Germany
$1.44M -$5.82K -89 -0.4%
Connor, Clark & Lunn Investment Management (CC&L)
175
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.41M -$317K -4,850 -18%
5 6
7
8 9

AZN Hedge Fund Activity: Q3 2016 in Review

449 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q3 2016, worth a combined $10.8B — up 24% from $8.72B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new AZN positions and 25 closed out — a net gain of 57 holders — while 154 added to existing stakes and 120 trimmed.

The largest buyer was Dodge & Cox, adding an estimated $316M. The largest seller was Arrowstreet Capital, cutting an estimated $212M.

  • 449 institutional investors held AstraZeneca (AZN) as of Q3 2016, up from 397 in Q2 2016.
  • Funds reported $10.8B of AstraZeneca stock for Q3 2016, up 24% quarter-over-quarter.
  • 82 funds opened new AstraZeneca positions in Q3 2016 and 25 closed out, a net change of +57 holders.
  • The largest AstraZeneca buyer in Q3 2016 was Dodge & Cox, an estimated $316M added.
  • The largest AstraZeneca seller in Q3 2016 was Arrowstreet Capital, an estimated $212M sold.

Based on aggregated 13F filings for Q3 2016.